Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Tuesday, November 11, 2025Revvity Inc today announced it has entered into a definitive agreement to acquire ACDLabs a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Tuesday, November 11, 2025Lyell Immunopharma Inc a latestage clinical company advancing nextgeneration chimeric antigen receptor CAR Tcell therapies for patients with cancer today announced it has strengthened its solid tumor pipeline by acquiring global rights to LYL formerl...
Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
Friday, November 07, 2025Takedatoday announced new interim data from the Phase b openlabel proofof concept study of subcutaneous mezagitamab TAK an antiCD monoclonal antibody with diseasemodifying potential in primary immunoglobulin A IgA nephropathy
U.S. FDA Grants Orphan Drug Designation to Leukogene Therapeutics’ M2T-CD33 (LTI-214) for the Treatment of Acute Myeloid Leukemia
Thursday, November 06, 2025Leukogene Therapeutics Inc LTI a biopharmaceutical company developing nextgeneration immunotherapies for hematologic and other malignancies today announced that the US Food and Drug Administration
PolyActiva and RareSight Form Strategic Collaboration to Develop Breakthrough Treatments for Rare Pediatric Retinal Diseases
Thursday, November 06, 2025PolyActiva a clinicalstage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions and RareSight Inc an ophthalmologyfocused life sciences company
Phenomix Sciences Expands Evidence for MyPhenome™ Test Predicting GLP-1 Response and Obesity Risk in Large, Diverse Populations
Wednesday, November 05, 2025Phenomix Sciences Phenomix the first commercial precision obesity medicine biotechnology company today announced results from new research presented at Obesity Week demonstrating the continued clinical utility
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
Tuesday, November 04, 2025Rein Therapeuticsa biopharmaceutical company advancing a novel pipeline of firstinclass medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications today announced that the US Food and Drug Administration
Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer's Disease
Tuesday, November 04, 2025Arctic Therapeutics ATx an Icelandbased clinicalstage biopharmaceutical company today announced key regulatory milestones for its lead investigational therapy AT
